Popular Articles

Shape Matters In The Case Of Cobalt Nanoparticles
Shape is turning out to be a particularly important feature of some commercially important nanoparticles - but in subtle ways. New studies* by scientists at the National Institute for Standards and Technology (NIST) show that changing the shape of cobalt nanoparticles from spherical to cubic can fundamentally change their behavior.
diet pills
Also In Global Health News: HIV & TB; ITN Program; DRC's Health System
HIV-Positive Babies More Likely To Contract Deadly TB If Given BCG
News of the day
1/4 Of Patients On Highest Investigational Doses Of CP-690,550 Achieve ACR70 At Week 12
A quarter of active rheumatoid arthritis (RA) patients receiving either 10mg (24.6%) or 15mg (28.1%) twice daily of the investigational oral JAK-3 (janus-associated kinase) inhibitor CP-690,550 (CP) achieved ACR70* after 12 weeks, according to the results of a new study presented at EULAR 2009, the Annual Congress of the European League Against Rheumatism in Copenhagen, Denmark. The primary outcome for the study was ACR20*, with 75.4% of patients achieving this measure at 12 weeks for both 10mg and 15mg doses.
Public Health

Drug-Free Flipping Of The Brain's Addiction Switch

When someone becomes dependent on drugs or alcohol, the brain"s pleasure center gets hijacked, disrupting the normal functioning of its reward circuitry. Researchers investigating this addiction "switch" have now implicated a naturally occurring protein, a dose of which allowed them to get rats hooked with no drugs at all. The research will be published Friday in the journal Science. "If we can understand how the brain"s circuitry changes in association with drug abuse, it could potentially suggest ways to medically counteract the effects of dependency," said Scott Steffensen, a neuroscientist at Brigham Young University who co-authored the study with two of his undergraduate students, one of his grad students, and a team of researchers at the University of Toronto. Chronic drug users, as noted by previous research, can experience an increase of a naturally-occurring protein called BDNF (brain-derived neurotrophic factor) in the brain"s reward circuitry, a region scientists call the ventral tegmental area. In this study, the researchers took the drugs out of the equation and directly infused extra BDNF onto this part of the brain in rats. The Toronto team noted that a single injection of BDNF made rats behave as though they were dependent on opiates (which they had never received). Though rats instinctively prefer certain smells, lighting and texture, these rats left their comfort zone in search of a fix. "This work may reveal a mechanism that underlies drug addiction," said lead author Hector Vargas-Perez, a neurobiologist at the University of Toronto. The BYU team confirmed that the protein is a critical regulator of drug dependency. After the BDNF injection, specific chemicals that normally inhibit neurons in this part of the brain instead excited them, a "switch" known to occur when people become dependent on drugs. Steffensen, who teaches in BYU"s psychology department, says this work suggests that BDNF is crucial for inducing a drug dependent state, one important aspect of drug addiction. BYU undergrad and study co-author Micah Hansen researched in Steffensen"s neuroscience lab from his freshman year through his graduation one month ago. Fellow BYU undergrad Christine Walton, also a coauthor, completed her degree a year earlier and now works as an addiction researcher at the National Institutes of Health in Bethesda, Md. David Allison, a psychology graduate student at BYU, is also a co-author. Joe Hadfield Brigham Young University


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):